Genco Shipping & Trading Limited has amended its Shareholder Rights Agreement, a defensive measure often called a "poison pill." The change, effective June 2, 2026, was made in response to shareholder feedback and primarily involves the elimination of the "Acting in Concert" provision from the agreement. The company stated the core purpose of the Rights Agreement remains to protect long-term shareholder value against coercive takeover tactics.
Key Details
- Agreement: The company entered into the Third Amendment to its Shareholder Rights Agreement on June 2, 2026.
- Primary Change: The amendment completely eliminates the defined term "Acting in Concert" from the Rights Agreement.
- Rationale: The Board of Directors cited shareholder feedback and its own assessment as the basis for the change, deeming it in the best interests of shareholders.
- Remaining Protections: Other provisions designed to protect shareholders, such as rules regarding the formation of a group under the Securities Exchange Act, remain unchanged.